Literature DB >> 17349784

ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival.

Pierre I Karakiewicz1, Quoc-Dien Trinh, Alexandre de la Taille, Claude C Abbou, Laurent Salomon, Jacques Tostain, Luca Cindolo, Walter Artibani, Vincenzo Ficarra, Jean-Jacques Patard.   

Abstract

OBJECTIVES: We tested and compared the improvement in prognostic ability related to the consideration of either ECOG performance status (ECOGPS) and/or symptom classification (S-CLASS) in renal cell carcinoma specific mortality (RCC-SM) predictions.
METHODS: Univariate and multivariate Cox regression analyses targeted RCC-SM in 2570 RCC patients treated with either partial or radical nephrectomy. The increment in predictive accuracy related to the addition of either ECOGPS, S-CLASS or both was quantified using Harrell's concordance index.
RESULTS: Follow-up ranged from 0.1 to 23 years (median 3.2) and 610 patients (23.7%) died of RCC. In multivariable analyses, ECOGPS and S-CLASS represented independent predictors of RCC-SM. The addition of ECOGPS to established RCC-SM predictors increased the predictive accuracy by 0.3% (p=0.8) versus 0.6% (p=0.5) for S-CLASS versus 0.6% (p=0.5) for both.
CONCLUSIONS: Neither ECOGPS nor S-CLASS improves the ability to predict RCC-SM. Therefore, these variables may be safely omitted when RCC-SM risk is quantified.

Entities:  

Mesh:

Year:  2007        PMID: 17349784     DOI: 10.1016/j.ejca.2007.01.020

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

Review 1.  Risk stratification and prognostication of renal cell carcinoma.

Authors:  Vincenzo Ficarra; Antonio Galfano; Giacomo Novara; Massimo Iafrate; Matteo Brunelli; Silvia Secco; Stefano Cavalleri; Guido Martignoni; Walter Artibani
Journal:  World J Urol       Date:  2008-04-08       Impact factor: 4.226

2.  Positive intratumoral chemokine (C-C motif) receptor 8 expression predicts high recurrence risk of post-operation clear-cell renal cell carcinoma patients.

Authors:  Qiang Fu; Yuan Chang; Lin Zhou; Huimin An; Yu Zhu; Le Xu; Weijuan Zhang; Jiejie Xu
Journal:  Oncotarget       Date:  2016-02-16

3.  High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.

Authors:  Zhiying Xu; Yidong Liu; Yuanfeng Yang; Jieti Wang; Guodong Zhang; Zheng Liu; Hangcheng Fu; Zewei Wang; Haiou Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2017-01-31

4.  The prognostic relevance of interactions between venous invasion, lymph node involvement and distant metastases in renal cell carcinoma after radical nephrectomy.

Authors:  Dragomir P Zubac; Leif Bostad; Tomas Seidal; Tore Wentzel-Larsen; Svein A Haukaas
Journal:  BMC Urol       Date:  2008-12-19       Impact factor: 2.264

5.  Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis.

Authors:  Qiang Fu; Yuan Chang; Huimin An; Hangcheng Fu; Yu Zhu; Le Xu; Weijuan Zhang; Jiejie Xu
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.